Rienso® (ferumoxytol): Risk of serious hypersensitivity reactions
2014.06.05
Active substance: ferumoxytol
The EMA is in the process of evaluating all worldwide data available on serious hypersensitivity reactions in connection with administration of the medicinal product Rienso® (ferumoxytol) which, however, is currently not being marketed in Germany.
risk information - full text (available in German only)
For more information visit: